SCHEMBL31728482

SCHEMBL31728482

Cn1cnc(COc2ccc(-c3ccc4ncsc4c3F)c3ncnc(N)c23)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31728594 0.84 SRC (0.35) —
SCHEMBL31727822 0.82 EIF2AK3 (0.31) —
SCHEMBL31728557 0.79 RPS6KA1 (0.31) —
SCHEMBL31727802 0.75 SRC (0.34) —
SCHEMBL31728043 0.72 LRRK2 (0.31) —
SCHEMBL31728572 0.69 — —
SCHEMBL31728886 0.69 KDR (0.34) —
SCHEMBL31727943 0.67 PIK3CD (0.35) —
SCHEMBL31728454 0.67 EIF2AK3 (0.36) —
SCHEMBL31727748 0.64 ABL1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback